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Luoni).Plant auto-inhibited Ca2+-ATPase 8 (ACA8) and animal plasma membrane Ca2+-ATPase 4b (PMCA4b)
are representatives of plant and animal 2B P-type ATPases with a regulatory auto-inhibitory domain
localized at the N- and C-terminus, respectively. To check whether the regulatory domain works
independently of its terminal localization and if auto-inhibitory domains of different organisms
are interchangeable, a mutant in which the N-terminus of ACA8 is repositioned at the C-terminus
and chimeras in which PMCA4b C-terminus is fused to the N- or C-terminus of ACA8 were analysed
in the yeast mutant K616 devoid of endogenous Ca2+-ATPases. Results show that the regulatory
function of the terminal domain is independent from its position in ACA8 and that the regulatory
domain belonging to PMCA4b is able to at least partially auto-inhibit ACA8.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction C-te, the auto-inhibitory, CaM- and phospholipid-binding domainCa2+-ATPases are enzymes that actively transporting Ca2+ in
eukaryotic cells play a key role in Ca2+ homeostasis [1,2]. They be-
long to the P-type ATPases forming a phosphorylated intermediate
during the catalytic cycle. Among these, 2B subgroup clusters both
animal PMCAs (plasma membrane Ca2+-ATPases) and plant ACAs
(auto-inhibited Ca2+-ATPases). P2B-type ATPases share a number
of catalytic and regulatory features [3–7] and are characterized
by an extended cytosolic regulatory domain with auto-inhibitory
function. The action of this domain can be suppressed by binding
of calmodulin (CaM) or acidic phospholipids setting the enzyme
in an activated state characterized by high Vmax and low K0.5 for
free Ca2+ [7–11].
Despite similar activation mechanism, some divergences can be
underlined: animal isoforms of PMCAs are highly speciﬁc for ATP
whereas plant ACAs have the unique ability to use GTP or ITP
nearly as well as ATP [4,14,15]. Moreover, the latter are localized
not only in plasma membrane (PM), but also in endomembranes
[1,4,6]. The main structural difference between PMCAs and ACAs
is the localization of the terminal regulatory domain. While in ani-
mal isoforms this domain is localized at the C-terminus (C-te) of
the protein, in plant isoforms, which have a very short cytosolicchemical Societies. Published by E
se; CaM, calmodulin; C, CaM-
a membrane; PMCA, animal
nza), laura.luoni@unimi.it (L.is localized at the N-terminus (N-te) [4,6–8,11,13]. In the absence
of any activator, this domain interacts intramolecularly within
the pump. In animals, cross-linking experiments using human
isoform PMCA4b and a peptide reproducing the sequence of the
CaM-binding site allowed the identiﬁcation of an intramolecular
receptor for the auto-inhibitory domain composed of two portions:
one is localized in the big cytoplasmic loop and the other in the
small cytoplasmic loop [7,16,17]. The latter region, which is part
of the actuator domain, is highly conserved among members of
the type 2B Ca2+-ATPases and a peptide reproducing this region
of ACA8, a PM localized isoform of Arabidopsis thaliana type 2B
Ca2+-ATPase [13], interacts with the N-te [18]. Moreover, single
point mutations in the small cytoplasmic loop generate a partially
deregulated pump [19]; if another intramolecular receptor exists
in ACA8, it has not been identiﬁed yet.
Regulation, although different, shares some common features
which would suggest a general mechanism for Ca2+ pumps auto-
inhibition, independently of the auto-inhibitory terminal domain
position or of the organism. In PMCA4b, repositioning of the regu-
latory C-te to the N-te side preserves the auto-inhibitory function,
although the C-te in the new position seems less effective [20].
To verify whether the auto-inhibitory domain acts indepen-
dently of its localization also in plant 2B Ca2+-ATPases a mutant
in which the N-te of ACA8 is inserted at the C-te of the protein
was constructed using the deregulated mutant D74ACA8 [15]. In
addition, to check if regulatory domains of different P2B-type
ATPases might be interchangeable, two different chimeras were
produced fusing the C-te domain of PMCA4b to the N- or C-te oflsevier B.V. All rights reserved.
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ACA8 to the C-te of the protein generates a fully auto-inhibited
mutant and that the regulatory domain belonging to PMCA4b is
able to partially inhibit ACA8 activity.
2. Materials and methods
2.1. D74ACA8-Nte116 mutant and chimeras construction
The fragment coding for the ﬁrst 116 aminoacids of ACA8 was
synthesized by PCR using the full-length cDNA of ACA8 as template
and the following primers: (forward) 50-CGTCCTCTCGAGATGACG
AGTCTCTTGAAGTCATC-30, (reverse) 50-CCTCAGTCTAGATCAAATTC
CAAAATCACCAGCCGG-30 ’.
The fragment coding for the C-te portion of PMCA4b (Thr1051-
Asn1180) was ampliﬁed by PCR using the full-length cDNA of
PMCA4b as template and the primers listed below: (forward) 50-
CGTCCTCTCGAGACCCGATCCCTGAAGTTCCTG-30, (reverse) 50-CCTC
AGTCTAGATCAGTTTGTATTGGCATATGGAGT-30. XhoI and XbaI
restriction sites (underlined) were introduced in both PCR products
to 50 and 30 ends, respectively during ampliﬁcation. For production
of D74ACA8-Nte116 mutant and of D74ACA8-PMCA4b chimera,
PCR products were inserted into the pYES2 vector containing the
sequence of the deregulated mutant D74ACA8 [15] cloned at the
unique sites KpnI and XhoI and previously depleted of the stop
codon. Insertion was performed at the XhoI site, corresponding
to 30 end ofD74ACA8 and XbaI site (pYES2D74ACA8-Nte116, pYES2
D74ACA8-PMCA4b). To create the PMCA4b-D74ACA8 chimera, the
fragment coding for the C-te portion of PMCA4b (Thr1051-Asn1180,
[20]) was ampliﬁed with KpnI restriction site (underlined) at both
50 and 30 ends using the following primers: (forward) 50-GTC
CTGGTACCATGACCCGATCCCTGAAGTTCCT30, (reverse) 50-CCTCAG
GGTACCGTTTGTATTGGCATATGGAGT-30 and then inserted with
the right orientation at the 50 end of D74ACA8 (pYES2:PMCA4b-
D74ACA8). The forward primer was also used to insert the start
codon (double underlined).
PCR was performed using TaqPlus Precision PCR System (Strat-
agene). Absence of errors were conﬁrmed by sequencing. The
resulting plasmids were used for yeast transformation.
2.2. Yeast transformation, complementation and growth media
Saccharomyces cerevisiae strain K616 (MAT pmr1::HIS3
pmc1::TRP1 cnb1::LEU2, ade2, ura3; [21]) was used for expression
of ACA8, D74ACA8-Nte116 mutant and two ACA8-PMCA4b chime-
ras. Yeast cells were transformed and selected as described before
[15]. Complementation analysis was performed as described
[15,19]. Plates were incubated incubated at 30 or 20 C as reported
in the ﬁgure legends for 3–5 days.
2.3. Isolation of yeast microsomes and protein puriﬁcation by CaM-
afﬁnity chromatography
Yeast microsomes expressing ACA8, D74ACA8-Nte116 or ACA8-
PMCA4b chimeras were isolated and solubilized as reported [19].
The solubilized proteins (0.6 mg or 6 mg for microsomes express-
ing ACA8 and ACA8-PMCA4b chimeras, respectively) were incu-
bated overnight at 4 C on 0.2 ml of CaM-sepharose gel (GE
Healthcare). Puriﬁcation was conducted as described [19]. The
1 mM EGTA eluted fractions were immediately assayed for Ca2+-
ATPase activity or used for electrophoresis.
2.4. Electrophoresis and immunoblotting analysis
SDS–PAGE, Western blotting and immunodecoration with anti-
serum against ACA8 sequence Glu268–Trp348 were performed asdescribed [18]. For the immunodecoration with anti-PMCA4b
monoclonal antibody JA3 (Santa Cruz Biotechnology, INC), the NC
membrane was incubated for 2 h at 25 C with the antibody di-
luted 1:500 in 3% (w/v) bovine serum albumin, 0.1% (w/v) polyoxy-
ethylene(20)sorbitan monolaurate, 0.15 M NaCl, 20 mM Tris–HCl,
pH 7.4. Signal detection was performed with an ECL anti-mouse
IgG antibody linked to horseradish peroxidase (Amersham Biosci-
ences), diluted 1:30,000 in the same solution reported. Alterna-
tively, gel was stained with a silver impregnation method (Sigma).
2.5. Assays of Ca2+-ATPase activity
The assay medium was as reported [19]. The indicated free Ca2+
concentrations were buffered with 1 mM EGTA [22] and incubation
was performed at 25 C for 60 min.
The hydrolytic activity of the puriﬁed proteins was measured as
Ca2+-dependentMgATPhydrolysis [13] using20 ll/sample of eluted
fraction.MgATPhydrolysis,measured in the presence of 1 mMEGTA
without added Ca2+, was subtracted from the reported data. The
hydrolytic activity of the microsomal fraction was measured as
eosin-sensitive MgATP hydrolysis [19] using 0.2 lM eosin Y and
4 lg/sample proteins. Bovine testes CaM (Sigma) was supplied at
1 lM, unless otherwise speciﬁed. All the assays were performed at
least three times with three replicates for each condition.3. Results
A mutant in which the N-te of ACA8 was moved to the C-te end
of the molecule was constructed by fusing the ﬁrst 116 aminoacids,
containing both the CaM-binding and auto-inhibitory domain
[18,23], to the deregulated and constitutively activated D74ACA8
mutant [15] (Fig. 1).
D74ACA8-Nte116 was expressed likewise ACA8 wt in yeast tri-
ple mutant K616 lacking the endogenous high afﬁnity Ca2+-ATPas-
es [21] (Fig. 2, top panel). It has previously been shown that ACA8
is not able to complement the K616 phenotype under Ca2+ stress
conditions unless the pump is deregulated either by removal of
the N-te or by point mutations in regulatory regions [15,19,23].
K616 expressing D74ACA8-Nte116 behaved as cells transformed
with ACA8 on selective medium (Fig. 2, bottom panel). The inabil-
ity to reverse the K616 phenotype strongly suggested that
D74ACA8-Nte116 could be auto-inhibited. This was conﬁrmed
assaying the Ca2+-ATPase activity (Fig. 2, middle panel): although
somewhat lower than the hydrolytic activity measured for ACA8,
the speciﬁc activity of D74ACA8-Nte116 indicated that the mutant
was functional and fully responsive to exogenous CaM being stim-
ulated by about ﬁve fold, similar to ACA8.
Fig. 3 reports the enzymatic activity of ACA8 and D74ACA8-
Nte116 as a function of free Ca2+ concentration measured in the
presence and absence of saturating concentration of CaM (upper
panel). Data analysis showed an identical behaviour for the wt
and the mutant protein that display the same Ca2+ afﬁnity in basal
conditions. CaM determined for both proteins a ﬁvefold increase in
the Vmax and a moderate decrease in the apparent K0.5 for Ca2+.
Moreover, the dependence of the Ca2+-ATPase activity of ACA8
andD74ACA8-Nte116 on CaM concentration was compared. The re-
sults reported in Fig. 3 (lower panel) are normalised to maximal
stimulation in order to highlight the concentration dependence
of hydrolytic activity. Estimation of the concentration of CaM re-
quired to obtain half-maximal stimulation revealed a value of
about 30 nM for both ACA8 and D74ACA8-Nte116 and indicated
that the two pumps bind CaM with the same afﬁnity.
To test whether auto-inhibitory domain of different P2B-type
ATPases may act through a similar mechanism independently
of the organism to which these pumps pertain, we produced
Fig. 1. Schematic representation of proteins used in the present study. The 10 transmembrane (TM) regions are indicated by dashed boxes; the calmodulin-binding and auto-
inhibitory domain of ACA8 is black. White boxes represent the C-terminal region of PMCA4b (aminoacids 1051–1180) containing the calmodulin-binding (C) and auto-
inhibitory (I) domain (dot spots).
Fig. 2. Expression of ACA8 and D74ACA8-Nte116 in yeast K616. Top panel:
immunodecoration of microsomal proteins (4 lg per lane) with an antiserum
against ACA8 [18]. Middle panel: basal (+Ca2+) and CaM-stimulated (+CaM) eosin-
sensitive ATPase speciﬁc activity (nmolPi min1 mg1 protein) measured in
presence of 10 lM free Ca2+ is reported ± standard error of the mean. Results are
from one experiment representative of ﬁve. Bottom panel: complementation of the
K616 phenotype on selective medium. Yeast cells transformed with ACA8 or mutant
D74ACA8-Nte116 were grown in SC-URA, 2% (w/v) glucose and 10 mM CaCl2 then
plated (25 ll) on SC-URA, 2% (w/v) galactose, 1% (w/v) rafﬁnose, 20 mM EGTA and
incubated for 3–5 days at 30 C. As control, K616 transformed with empty pYES2
vector (EV) or with the deregulated mutant D74ACA8 were used. Results are from
one experiment representative of four.
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ulatory domain of isoform 4b of human PMCA [7,12,20,25]. Two
different chimeras were created: D74ACA8-PMCA4b with the reg-
ulatory C-te of PMCA4b localized at the C-te of D74ACA8 and
PMCA4b-D74ACA8 in which the C-te of PMCA4b was fused at
the N-te of D74ACA8 (Fig. 1).
The D74ACA8-PMCA4b chimera was expressed in K616 (Fig. 4,
top panel, lane 3), although the expression level was much lower
than that of ACA8 (lane 1) or D74ACA8 mutant (lane 2). A ﬁrst
evaluation of auto-inhibition was performed testing its ability to
complement the K616 phenotype on the selective medium. Expres-
sion of D74ACA8-PMCA4b only partially restored cell growth
(Fig. 4, bottom panels B and C). In standard conditions (30 C) thePMCA4b-D74ACA8 chimera was expressed but extensively prote-
olysed as evident by the presence of a faint signal with the appar-
ent mass expected for the recombinant protein and an intense
signal at a molecular mass similar to that of D74ACA8 (Fig. 4, top
panel, lane 4). K616 cells transformed with PMCA4b-D74ACA8
grew, on selective medium, similarly to cells expressing the fully
deregulated D74ACA8 (Fig. 4, bottom panels B and C). The integrity
of PMCA4b-D74ACA8 was greatly improved inducing its expres-
sion at 20 C (Fig. 4, top panel, lane 5); in these experimental con-
ditions, K616 cells expressing this chimera grew poorly on 20 mM
EGTA as did those expressing the fully auto-inhibited ACA8 (Fig. 4,
bottom panels B and C).
Due to the low expression level of the chimeras in microsomes,
the analysis of these mutants was performed evaluating their re-
sponse to CaM after one-step puriﬁcation on CaM-sepharose.
While ACA8 was puriﬁed to virtual homogeneity (Fig. 5A, lane 1),
the electrophoresis analysis of the puriﬁed fractions of D74ACA8-
PMCA4b and PMCA4b-D74ACA8 (lanes 2 and 3, respectively)
revealed a main band at 124 kDa, corresponding to the mass of
full-length chimeras, accompanied by slightly smaller molecular
mass bands of lower intensity.
An anti-PMCA4b antibody reacting with the C-te of the animal
pump strongly recognised the full-length chimeras and one of
the lower bands of PMCA4b-D74ACA8 suggesting that puriﬁed
fractions contained partial degradation products lacking at least
part of the C-te auto-inhibitory domain of PMCA4b (Fig. 5A, lanes
4 and 5). The fully auto-inhibited ACA8 had a very low basal
Ca2+-ATPase activity which was stimulated more than ﬁvefold by
CaM (Fig. 5B, sample 1). Both D74ACA8-PMCA4b and PMCA4b-
D74ACA8 were functional and CaM-sensitive: their activities were
stimulated by addition of CaM by about 2 and 1.8 fold, respectively
(Fig. 5B, samples 2 and 3) indicating that both chimeras were
partially auto-inhibited by the C-te domain of PMCA4b.
4. Discussion
To test the hypothesis that the terminal regulatory domains of
different P2B-type ATPases share similar mechanisms of auto-inhi-
bition despite their different localization in the protein and
differences in the source organism, we used as models ACA8 and
PMCA4b, the best characterized isoforms of P2B-type Ca2+-
ATPase of A. thaliana and of mammals, respectively [4,6,7,11–13,
15,18,19,23,24].
Repositioning of the ﬁrst 116 aa of ACA8 containing the overlap-
ping CaM-binding and auto-inhibitory regions [13,18,23], at the C-
te of the deregulated D74ACA8 [15] generates a functional mutant
that maintains the same kinetics properties as the wt ACA8. This
mutant is fully auto-inhibited and CaM-stimulated. Evaluation of
the afﬁnity for CaM displays a value of K0,5 of about 30 nM for both
ACA8 and D74ACA8-N-te116 mutant. This value is very similar to
Fig. 3. Characterization of ACA8 and D74ACA8-Nte116 mutant hydrolytic activity.
Top panel: dependence of Ca2+-ATPase activity on free Ca2+ concentration evaluated
in presence (closed symbols) and absence (open symbols) of 1 lM CaM. Ca2+-
ATPase activity of microsomal fraction puriﬁed from yeast expressing wt (j,h) or
D74ACA8-Nte116 (d,s) protein was measured as eosin-sensitive ATPase activity at
the speciﬁed free Ca2+ concentrations. Enzyme activity is expressed as the ratio
between activity measured at the indicated free Ca2+ concentrations and maximal
activity evaluated at saturating free Ca2+ concentration in the presence of CaM.
Results are from one experiment representative of three. Vmax (nmol Pi min1 mg1
protein) and apparent K0.5 for free Ca2+ (lM) were evaluated by regression analysis
of the data coming from the three experiments as reported [11]. ACA8: Vmax 31 ± 4
in absence and 168 ± 16 in presence of CaM, K0.5 for free Ca2+ 8 ± 1 in absence and
5 ± 1 in presence of CaM; D74ACA8-N-te116 mutant: Vmax 22 ± 4 in absence and
120 ± 11 in presence of CaM, K0.5 for free Ca2+ 10 ± 2 in absence and 4 ± 1 in
presence of CaM. Lower panel: Activation as a function of CaM concentration. Ca2+-
ATPase activity of microsomal fraction puriﬁed from yeast expressing wt (j) or
D74ACA8-Nte116 (d) protein was measured as eosin-sensitive ATPase activity in
the presence of 10 lM free Ca2+ at the speciﬁed CaM concentrations. Enzyme
stimulation (f/fmax) is expressed as the ratio between % of activation at the
indicated CaM concentrations (f) and maximal activation evaluated at saturating
CaM concentration (fmax; 360% for ACA8 and 410% for D74ACA8-N-te116 mutant).
Results are from one representative of four different experiments. Analysis of all the
data allowed the estimation of the apparent K0.5 for CaM (±SE): 29.3 ± 1.6 nM and
30.4 ± 1.9 nM for ACA8 and D74ACA8-N-te116 mutant, respectively.
Fig. 4. Expression of ACA8-PMCA4b chimeras in K616. Top panel: 4 lg of
microsomal proteins from cells transformed with ACA8 (lane 1) and D74ACA8
(lane 2) or 10 lg from cells transformed with D74ACA8-PMCA4b (lane 3) and
PMCA4b-D74ACA8 (lane 4) were immunodecorated with anti-ACA8 antiserum
[18]. Lane 5 was loaded with 10 lg of proteins from K616 expressing PMCA4b-
D74ACA8 at 20 C. Bottom panels: complementation of the K616 phenotype.
Precultures of K616 transformed with ACA8, D74ACA8, D74ACA8-PMCA4b and
PMCA4b-D74ACA8 grew in synthetic complete medium lacking uracil (SC-URA), 2%
(w/v) glucose, 10 mM CaCl2 were pelletted, washed and diluted with water. Five ll
of cells at A600 = 1.0 were spotted on SC-URA, 2% (w/v) glucose, 10 mM CaCl2 (A) or
5 ll of cells at A600 = 1 (B) or A600 = 0.3 (C), were spotted on SC-URA, 2% (w/v)
galactose, 1% (w/v) rafﬁnose, 20 mM EGTA. Plates were incubated for 3 days at 30 C
(spots corresponding to lanes 1–4) or at 20 C (spots corresponding to lane 5).
Results are from one experiment representative of four.
Fig. 5. Analysis of CaM-afﬁnity puriﬁed ACA8 and chimeric proteins. (A) Silver
staining of puriﬁed ACA8 (lane 1, 2.5 ll), D74ACA8-PMCA4b (lane 2, 12 ll) and
PMCA4b-D74ACA8 (lane 3, 12 ll). Fifteen ll of puriﬁed D74ACA8-PMCA4b (lane 4)
and PMCA4b-D74ACA8 (lane 5) have been immunodecorated with anti-PMCA4b.
(B) Basal (dashed bars) and CaM-stimulated (black bars) Ca2+-dependent ATPase
activity of puriﬁed fractions in presence of 10 lM Ca2+. Activity is expressed as per
cent of the molecular activity measured in the presence of CaM (290 min1 for
ACA8, lane 1; 61 min1 for D74ACA8-PMCA4b, lane 2 and 81 min1 for PMCA4b-
D74ACA8, lane 3). Molecular activities have been determined using b-galactosidase
as a standard for protein quantiﬁcation as reported [19]. Results are from one of ﬁve
experiments, performed on puriﬁed fractions coming from different puriﬁcation
trials. Bars represent ± standard error of the mean.
4786 M.C. Bonza, L. Luoni / FEBS Letters 584 (2010) 4783–4788the apparent KD for CaM measured with the same approach for
both the native A. thaliana PM Ca2+-ATPase in isolated plasma
membranes and the puriﬁed enzyme and to that determined by
surface plasmon resonance using CaM and a peptide reproducing
the N-terminus of ACA8 [24].
Altogether these results show that the regulatory function of
the terminal domain is unrelated to the position at the N- or C-te
in ACA8. A similar result has been obtained relocating the C-te do-
main of PMCA4b near the N-te of the molecule, although in the
M.C. Bonza, L. Luoni / FEBS Letters 584 (2010) 4783–4788 4787new position the C-te of PMCA4b seemed to be less efﬁcient than
in the wt [20]. This ability to exert the regulatory function at both
ends of the pumps could reﬂect the ﬂexibility of these terminal
domains that allows them to reach the intramolecular target site.
To check if regulatory domains of P2B-type ATPases belonging
to different organisms are interchangeable, we produced and ana-
lysed both in vivo and in vitro two different chimeras in which the
C-te of PMCA4b is fused at the C-te of D74ACA8, thus mimicking
the original position of the regulatory domain in the animal pump
or at the N-te of D74ACA8, in the position corresponding to that of
the auto-inhibitory domain in plant P2B-type Ca2+-ATPases. The
PMCA4b segment used for construction of the chimeric proteins
contains the CaM-binding domain (C), which also inhibits the
pump, and a downstream region (I) that contributes to an extra
degree of auto-inhibition and thus includes all the regulatory
elements of the PMCA4b C-te [7,20,25].
These chimeras are functionally expressed in the yeast triple
mutant K616 even if the expression level of both chimeras is signif-
icantly lower than that of ACA8 wt or D74ACA8 mutant. To assess
any possible inhibitory effect of the PMCA4b regulatory C-te do-
main on ACA8, it is essential to analyse functional and intact chi-
meras. At 30 C, the standard growth temperature, K616 cells
produce a highly degradated PMCA4b-D74ACA8, with a molecular
mass similar toD74ACA8, that in vivo on selective medium confers
to the cells a behaviour very similar to that of the deregulated
ACA8 mutant. We partially solved the degradation problems of
PMCA4b-D74ACA8 growing yeast cells at 20 C. In these experi-
mental conditions we increased the integrity of this chimera and
thus we were able to analyse the auto-inhibitory state of the
almost intact protein.
Our results demonstrate that the regulatory C-te of the mam-
malian P2B-type Ca2+-ATPase at least partially inhibits ACA8, in
fact: (a) the expression of whole chimeras only partially comple-
ment the triple yeast mutant phenotype, allowing K616 cells to
grow poorly on the selective medium; (b) after partial puriﬁcation
of the proteins, Ca2+-ATPase activity of both chimeras is increased
about two fold by addition of exogenous CaM. This indicates that
the chimeric proteins are functional, partially auto-inhibited and
responsive to CaM excluding that the poor growth of K616 cells
on Ca2+-depleted medium is related to their low expression level.
Accordingly, at 30 C even if PMCA4b-D74ACA8 is expressed in
much lower amounts compared to D74ACA8, its expression fully
complements the K616 phenotype.
It is worth noting that in the puriﬁed fractions used to assay the
Ca2+-ATPase activity and the CaM-sensitivity of chimeric proteins
the presence of partially degradated products is still evident. These
protein fragments are not recognised by a monoclonal antibody di-
rected against the extreme C-te of PMCA4b and are thus lacking all,
or at least part, of the PMCA4b regulatory domain. As a conse-
quence, the reported CaM-stimulation of D74ACA8-PMCA4b and
PMCA4b-D74ACA8 might be underestimated.
It has been recently reported that in PMCA4b both the N- and C-
terminus are in close proximity in the auto-inhibited conforma-
tion. A rearrangement of both ends takes place when the pump
achieves the activated conformation, suggesting that the relative
position of both termini could be involved in the activation status
of PMCA4b [26]. In accordance, the auto-inhibitory function of the
regulatory domain of PMCA4b seems not to be related to its posi-
tion in the chimeras. Nevertheless, the entity of CaM-stimulation
observed is slightly higher when the regulatory domain of PMCA4b
is inserted either at the C-te of D74ACA8. This difference in CaM-
stimulation between the two chimeras is in agreement with the re-
sults formerly reported for a mutant in which the C-te of PMCA4b
had been relocated at the N-te of the animal pump. It was proposed
that the partial auto-inhibition of this mutant could be ascribed to
the relative position of C and I portions of the regulatory domain:while the function of the C is preserved in the new position, the
correct functioning of I would require its location to be closer than
the C region to the extreme of the molecule [20].
The hypothesis that an intramolecular receptor for different I is
conserved among different P-type ATPases has been suggested by
results obtained on the hydrolytic activity of different Ca2+ pumps
in isolated membranes. Synthetic CaM-binding peptides corre-
sponding to the terminal auto-inhibitory domain of a PMCA or
an ACA inhibit a type 2A Ca2+-ATPase of sarco-endoplasmic reticu-
lum from skeletal muscle [27] and of the endoplasmic reticulum of
A. thaliana [28], respectively. However, the inhibitory effect was
only tested in vitro and with a large excess of peptides and these
studies were limited to the same organism.
Here we clearly demonstrate that the auto-inhibitory function
of the terminal domain is maintained both in vivo and in vitro in
different correctly folded chimeric proteins constructed by fusing
two different P2B-type ATPases belonging to different organisms
that are as evolutionary distant as A. thaliana and the human being.
ACA8 and PMCA4b are about 40% identical in their aminoacid se-
quences and share very similar regulatory proprieties; the main
difference is related to the localization of their regulatory domains
at opposite termini of the protein. Moreover, these domains are so
poorly conserved in their aminoacid sequences that is impossible
to align them. Our data show that these domains are interchange-
able thus indicating that the differences in the aminoacidic se-
quence do not affect the tertiary structure of the protein.
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